Mylan and Pfizer Names Viatris as the New Company for Mylan-Upjohn's Combination
Shots:
- The name Viatris symbolizes the new company's goal of providing a path- “VIA’ —to three—"TRIS"—core goals: expanding access to medicines- leading by innovating to meet patient needs and being a trusted partner for the healthcare community worldwide
- Viatris to bring together Upjohn's position in China and emerging markets with Mylan's presence in the US and Europe- allowing the new company to have expanded geographic reach for its portfolio and future pipeline
- The new name- Viatris will be effective upon closing of the combination- which is expected to occur in H2’20. The two companies will continue to operate as independent- separate organizations until close
Click here to read full press release/ article | Ref: Mylan | Image: Business line
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com